GO:0033550 MAP kinase tyrosine phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033550 (MAP kinase tyrosine phosphatase activity) is a molecular function that removes phosphate from tyrosine residues on MAP kinases, directly opposing MAP kinase signalling [1,2,3].
• The reaction catalysed is: MAP kinase tyrosine phosphate + H2O = MAP kinase tyrosine + phosphate, as defined by QuickGO.
• Key enzymes include dual-specificity phosphatases such as PAC1 (DUSP2), MSG5, MKP1, MKP2, and tyrosine-specific phosphatases such as HePTP, PTP2, PTP3, and SHP2 [2,3,6,7,8].
• This activity is conserved from yeast to plants and mammals, where it controls processes including mating, stress responses, immune regulation, and neuronal survival [3,4,5,6,7].
• Dysregulation of MAP kinase tyrosine phosphatases is implicated in cancer, inflammatory diseases, and neurological disorders, making them attractive drug targets [4,7,8].
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential to dissect the specific roles of these phosphatases in health and disease.
Description
MAP kinase tyrosine phosphatase activity (GO:0033550) is a molecular function that catalyses the removal of phosphate from tyrosine residues on mitogen-activated protein (MAP) kinases, thereby attenuating MAP kinase signalling [1,2,3]. This activity is critical for maintaining the balance of phosphorylation that governs cellular responses to growth factors, stress, and cytokines. The QuickGO definition states: Catalysis of the reaction: MAP kinase tyrosine phosphate + H2O = MAP kinase tyrosine + phosphate. This function is carried out by a diverse group of enzymes, including dual-specificity phosphatases (DUSPs) and classical protein tyrosine phosphatases (PTPs) [2,3,4]. Researchers study this activity because MAP kinase pathways are central to cell proliferation, differentiation, and survival, and their dysregulation underlies many human diseases, including cancer and neurodegeneration [4,7]. For example, the tyrosine phosphatase HePTP specifically dephosphorylates ERK2, thereby modulating T-cell signalling. In Saccharomyces cerevisiae, tyrosine-specific phosphatases PTP2 and PTP3 differentially regulate the FUS3 MAP kinase during mating. These examples highlight the evolutionary conservation and functional specificity of MAP kinase tyrosine phosphatases. Understanding GO:0033550 is essential for designing experiments that manipulate MAP kinase signalling with precision. This article provides a comprehensive overview of the mechanism, key genes, disease relevance, and research methods, with a focus on CRISPR-based models for functional studies.
MAP kinase tyrosine phosphatase activity At A Glance
| GO ID | GO:0033550 |
|---|---|
| GO term | MAP kinase tyrosine phosphatase activity |
| Ontology | molecular_function |
| Synonym | tyrosine-specific MAP kinase phosphatase activity |
| Major function | Dephosphorylation of tyrosine residues on MAP kinases, attenuating MAP kinase signalling |
| Reaction | MAP kinase tyrosine phosphate + H2O = MAP kinase tyrosine + phosphate |
| Substrates | MAP kinases such as ERK2, FUS3, p38 |
| Representative enzymes | PAC1 (DUSP2), HePTP, PTP2, PTP3, MSG5, MKP1, MKP2, SHP2 |
| Conservation | Found in yeast, plants, and mammals |
What Is GO:0033550?
MAP kinase tyrosine phosphatase activity (GO:0033550) is defined as the catalysis of the reaction: MAP kinase tyrosine phosphate + H2O = MAP kinase tyrosine + phosphate. In other words, it is an enzymatic activity that removes a phosphate group from a tyrosine residue on a MAP kinase protein, using water as a co-substrate. This activity directly reverses the phosphorylation events that activate MAP kinases, thereby serving as a negative regulator of MAP kinase signalling pathways [1,2,3].
Why Is MAP kinase tyrosine phosphatase activity Important in Cell Biology?
MAP kinase tyrosine phosphatase activity is crucial because it provides a precise off-switch for MAP kinase pathways, which control fundamental cellular decisions such as proliferation, differentiation, stress responses, and survival [1,2,3,4]. Dysregulation of this activity can lead to uncontrolled MAP kinase signalling, a hallmark of many cancers and inflammatory diseases [4,8]. Moreover, specific phosphatases like SHP2 modulate p38 MAP kinase to promote neuronal survival, linking this activity to neuroprotection. Therefore, understanding GO:0033550 is essential for both basic biology and therapeutic development.
• Controls the duration and intensity of MAP kinase signalling, preventing excessive or aberrant activation [1,2].
• Regulates immune cell function, including T-cell activation via HePTP-mediated ERK2 dephosphorylation.
• Modulates stress responses and neuronal survival through SHP2-p38 signalling.
• Influences plant development, as shown by MKP1 regulation of blue light-mediated seedling growth.
• Plays a role in yeast mating and differentiation via PTP2/PTP3 and MSG5.
• Implicated in cancer, where loss of phosphatase activity can lead to oncogenic MAP kinase activation.
• Potential target for anti-inflammatory therapies, as MKP2 regulates macrophage-adipocyte interaction.
• Provides a mechanism for crosstalk between cAMP and MAP kinase pathways.
• Essential for developmental processes across species, from yeast to mammals [3,4,6].
• Offers a paradigm for understanding dual-specificity phosphatases in health and disease.
Molecular Mechanism of MAP kinase tyrosine phosphatase activity
Substrate recognition and binding
In simple terms: The phosphatase enzyme finds and grabs onto its target MAP kinase protein.
MAP kinase tyrosine phosphatases specifically recognize MAP kinases through interactions that often involve the kinase interaction motif (KIM) or other docking sites. For example, HePTP binds ERK2 with high specificity, forming a complex that leads to ERK2 dephosphorylation. In yeast, PTP2 and PTP3 selectively dephosphorylate the FUS3 MAP kinase, demonstrating substrate specificity.
Catalytic dephosphorylation
In simple terms: The enzyme removes a phosphate group from a tyrosine on the MAP kinase.
The catalytic mechanism involves a conserved cysteine residue in the phosphatase active site that performs a nucleophilic attack on the phosphate group of the phosphotyrosine, forming a covalent intermediate. Hydrolysis then releases phosphate and regenerates the enzyme [3,4]. This reaction directly inactivates the MAP kinase by removing the phosphate required for its active conformation [1,2].
Regulation by crosstalk and feedback
In simple terms: Other signalling pathways can influence how well the phosphatase works.
MAP kinase tyrosine phosphatase activity is subject to regulation by crosstalk with other pathways. For instance, cAMP-dependent kinase (PKA) can modulate a protein tyrosine phosphatase that acts on MAP kinase, providing a mechanism for signal integration. Additionally, the expression and activity of these phosphatases can be induced by MAP kinase activation itself, forming negative feedback loops.
Dual-specificity versus tyrosine-specific phosphatases
In simple terms: Some enzymes remove phosphate from both tyrosine and threonine, while others only target tyrosine.
While GO:0033550 specifically refers to tyrosine phosphatase activity, many enzymes that carry out this function are dual-specificity phosphatases (DUSPs) that can dephosphorylate both tyrosine and threonine residues on MAP kinases [3,4]. For example, PAC1 (DUSP2) is a dual-specificity phosphatase that controls MAP kinase activation. In contrast, HePTP and PTP2/PTP3 are tyrosine-specific [2,6]. This distinction is important for understanding substrate specificity and designing selective inhibitors.
Physiological impact of dephosphorylation
In simple terms: Removing the phosphate changes what the cell does, such as stopping growth or promoting survival.
Dephosphorylation of MAP kinases by these phosphatases can have diverse physiological outcomes. In neurons, SHP2-mediated dephosphorylation of p38 MAP kinase promotes survival by modulating caspase activity. In macrophages, MKP2 regulates interactions with adipocytes, influencing metabolic and inflammatory responses. Thus, the same enzymatic activity can lead to context-dependent effects.
Key Genes Involved in GO:0033550 MAP kinase tyrosine phosphatase activity
The following genes encode proteins that exhibit MAP kinase tyrosine phosphatase activity or directly regulate it, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DUSP2 (PAC1) | Dual-specificity phosphatase that dephosphorylates MAP kinases | Controls MAP kinase activation; studied in immune cells and cancer |
| PTPN7 (HePTP) | Tyrosine-specific phosphatase for ERK2 | Regulates T-cell signalling; target for autoimmune diseases |
| PTPN11 (SHP2) | Tyrosine phosphatase that modulates p38 MAP kinase | Promotes neuronal survival; implicated in cancer and Noonan syndrome |
| DUSP1 (MKP1) | Dual-specificity phosphatase | Regulates blue light-mediated seedling development in Arabidopsis |
| DUSP4 (MKP2) | Dual-specificity phosphatase | Regulates macrophage-adipocyte interaction; involved in inflammation |
| PTP2 | Tyrosine-specific phosphatase in yeast | Differentially regulates FUS3 MAP kinase during mating |
| PTP3 | Tyrosine-specific phosphatase in yeast | Differentially regulates FUS3 MAP kinase during mating |
| MSG5 | Dual-specificity phosphatase in yeast | Regulates FUS3 MAP kinase |
| DUSP5 | Dual-specificity phosphatase | Negative regulator of ERK signalling; reviewed in |
| DUSP6 | Dual-specificity phosphatase | Cytoplasmic ERK-specific phosphatase; reviewed in |
| DUSP7 | Dual-specificity phosphatase | Regulates ERK and p38; reviewed in |
| DUSP8 | Dual-specificity phosphatase | Regulates JNK and p38; reviewed in |
| DUSP9 | Dual-specificity phosphatase | Regulates ERK, JNK, p38; reviewed in |
| DUSP10 | Dual-specificity phosphatase | Regulates JNK and p38; reviewed in |
| DUSP16 | Dual-specificity phosphatase | Regulates JNK and p38; reviewed in |
| PTPN5 (STEP) | Tyrosine phosphatase | Regulates MAP kinases in neurons; reviewed in |
| PTPRR | Tyrosine phosphatase | Regulates ERK in neurons; reviewed in |
How Is MAP kinase tyrosine phosphatase activity Regulated?
MAP kinase tyrosine phosphatase activity is regulated at multiple levels. Transcriptionally, many DUSP genes are immediate-early genes induced by MAP kinase activation, creating negative feedback loops. Post-translationally, phosphatase activity can be modulated by phosphorylation, ubiquitination, and subcellular localization. For example, cAMP-dependent kinase can regulate a protein tyrosine phosphatase that acts on MAP kinase, illustrating crosstalk between pathways. Additionally, the activity of SHP2 is controlled by its SH2 domains, which auto-inhibit the phosphatase until engaged by phosphotyrosine ligands. In yeast, PTP2 and PTP3 are differentially regulated to control FUS3 MAP kinase during mating.
MAP kinase tyrosine phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTPN11 (SHP2) | Noonan syndrome, leukaemia, neuronal survival | Knock-in mouse models with gain-of-function mutations; neuronal cell lines |
| DUSP1 (MKP1) | Cancer, inflammation | Knockout mice; cancer cell lines |
| DUSP4 (MKP2) | Metabolic syndrome, inflammation | Macrophage-adipocyte co-culture; knockout mice |
| PTPN7 (HePTP) | Autoimmune diseases, T-cell signalling | Jurkat T cells with knockout or overexpression |
| PTPN5 (STEP) | Alzheimer's disease, schizophrenia | Neuronal cultures; knockout mice |
Cancer
Dysregulation of MAP kinase tyrosine phosphatases can lead to aberrant MAP kinase signalling, which is a hallmark of many cancers. For instance, loss of DUSP1 or DUSP4 expression has been associated with tumour progression, while SHP2 (PTPN11) mutations are found in leukaemias and solid tumours [4,7]. Targeting these phosphatases is a promising therapeutic strategy.
Neurological disorders
SHP2 modulates p38 MAP kinase and caspase 1 and 3 to foster neuronal survival, suggesting that its dysregulation may contribute to neurodegenerative diseases. Similarly, other tyrosine phosphatases like STEP (PTPN5) regulate MAP kinases in neurons and are implicated in Alzheimer's disease and schizophrenia.
Inflammatory and metabolic diseases
MKP2 (DUSP4) regulates macrophage-adipocyte interaction, influencing inflammation and insulin resistance. HePTP (PTPN7) controls ERK2 in T cells, and its dysregulation can lead to autoimmune responses. Thus, MAP kinase tyrosine phosphatases are potential targets for anti-inflammatory and metabolic therapies.
From MAP kinase tyrosine phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of a phosphatase on MAP kinase signalling? | CRISPR knockout cell lines or mice |
| How does a specific point mutation in the catalytic domain affect phosphatase activity? | CRISPR point-mutation knock-in |
| What is the impact of a disease-associated mutation on protein function? | Knock-in of mutant allele |
| Where and when is the phosphatase expressed? | Tagged knock-in (e.g., GFP) for imaging |
| What happens when the phosphatase is overexpressed? | CRISPR activation or overexpression constructs |
| Which genes are regulated by the phosphatase? | CRISPR knockout followed by RNA-seq |
How to Study the MAP kinase tyrosine phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro phosphatase assay | Catalytic activity of the phosphatase | Enzyme kinetics, inhibitor screening [2,3] |
| Phospho-Western blot | Phosphorylation status of MAP kinases | Signalling pathway analysis [1,2,7] |
| CRISPR knockout screen | Genes required for MAP kinase activity | Discovery of novel regulators |
| RNA-seq | Transcriptional changes upon phosphatase manipulation | Pathway analysis, biomarker discovery |
| Co-immunoprecipitation | Protein-protein interactions | Identification of substrates and regulators |
| Immunofluorescence | Subcellular localization of phosphatases | Spatiotemporal regulation studies |
| Mass spectrometry | Phosphoproteome changes | Global mapping of dephosphorylation targets |
| Yeast two-hybrid | Binary protein interactions | Screening for binding partners |
Phosphatase activity assays
In vitro phosphatase assays using recombinant enzymes and synthetic phosphopeptide substrates derived from MAP kinases can directly measure catalytic activity. These assays are often used to validate inhibitors or mutants [2,3].
Phospho-specific Western blotting
Western blots with antibodies against phosphorylated MAP kinases (e.g., phospho-ERK, phospho-p38) are used to assess the impact of phosphatase knockout or overexpression on MAP kinase phosphorylation status [1,2,7].
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate MAP kinase signalling, including phosphatases. These screens are powerful for discovering novel regulators and drug targets.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify substrates and interaction partners of MAP kinase tyrosine phosphatases. For example, affinity purification coupled to mass spectrometry has been used to map the interactome of HePTP.
How CRISPR Can Be Used to Study GO:0033550 MAP kinase tyrosine phosphatase activity
Knockout
CRISPR knockout of a MAP kinase tyrosine phosphatase gene (e.g., DUSP1, PTPN7) can reveal its role in regulating MAP kinase signalling. For example, knockout of HePTP in Jurkat T cells leads to hyperactivation of ERK2, demonstrating its function as a negative regulator.
Point Mutation
Introducing point mutations in the catalytic cysteine of a phosphatase (e.g., Cys to Ser) abolishes its activity, allowing researchers to separate catalytic from scaffolding functions. Such mutants can be generated via CRISPR-mediated homology-directed repair [3,4].
Knock-in
Knock-in of disease-associated mutations (e.g., SHP2 mutations found in Noonan syndrome) into the endogenous locus provides physiologically relevant models to study altered MAP kinase signalling.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of a phosphatase can be used to study the effects of excess activity on MAP kinase pathways, often leading to reduced proliferation or altered differentiation [4,5].
How EDITGENE Supports MAP kinase tyrosine phosphatase activity Research
Researchers studying MAP kinase tyrosine phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signalling pathway or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for MAP kinase tyrosine phosphatase activity research.
Frequently Asked Questions About MAP kinase tyrosine phosphatase activity
What is MAP kinase tyrosine phosphatase activity?
It is a molecular function (GO:0033550) that removes phosphate from tyrosine residues on MAP kinases, thereby inactivating them [1,2,3].
What genes are involved in MAP kinase tyrosine phosphatase activity?
Key genes include DUSP2 (PAC1), PTPN7 (HePTP), PTPN11 (SHP2), DUSP1 (MKP1), DUSP4 (MKP2), and yeast PTP2, PTP3, and MSG5 [2,3,5,6,7,8].
How does MAP kinase tyrosine phosphatase activity regulate cell signalling?
By dephosphorylating MAP kinases, these phosphatases act as negative regulators, preventing excessive or prolonged signalling [1,2,4].
What diseases are associated with MAP kinase tyrosine phosphatases?
They are implicated in cancer, neurological disorders, inflammatory diseases, and metabolic syndrome [4,7,8].
What is the difference between dual-specificity and tyrosine-specific MAP kinase phosphatases?
Dual-specificity phosphatases can dephosphorylate both tyrosine and threonine residues, while tyrosine-specific phosphatases only target tyrosine [3,4,6].
How can I study MAP kinase tyrosine phosphatase activity in the lab?
Common methods include in vitro phosphatase assays, phospho-Western blots, CRISPR knockout screens, and RNA-seq [2,3,4].
What are the substrates of MAP kinase tyrosine phosphatases?
Substrates include ERK2, p38, JNK, and yeast FUS3 MAP kinases [2,6,7].
Is MAP kinase tyrosine phosphatase activity conserved across species?
Yes, it is found in yeast, plants, and mammals, indicating evolutionary conservation [3,4,5,6].
Can CRISPR be used to study MAP kinase tyrosine phosphatases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for functional studies [2,4,7].
What are the potential therapeutic implications of targeting MAP kinase tyrosine phosphatases?
Modulating their activity could treat cancers, autoimmune diseases, and neurodegenerative disorders [4,7,8].
Conclusion
MAP kinase tyrosine phosphatase activity (GO:0033550) is a fundamental molecular function that controls the duration and intensity of MAP kinase signalling. Through the action of dual-specificity and tyrosine-specific phosphatases, it regulates diverse processes from yeast mating to human neuronal survival [1,2,3,6,7]. Dysregulation of this activity contributes to cancer, inflammation, and neurological diseases, making it a promising therapeutic target [4,7,8]. CRISPR-based models are indispensable for dissecting the specific roles of individual phosphatases. EDITGENE offers a comprehensive suite of services, from knockout and point mutation to library screening, to support researchers in this field. By leveraging these tools, the scientific community can accelerate discoveries that translate into novel treatments.
References
- 1. Saxena M et al.. 1999. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase.. Nat Cell Biol 1(5):305-11 PMID: 10559944
- 2. Pettiford SM et al.. 2000. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.. Oncogene 19(7):858-69 PMID: 10702794
- 3. Ward Y et al.. 1994. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1.. Nature 367(6464):651-4 PMID: 8107850
- 4. Seternes OM et al.. 2019. Dual-specificity MAP kinase phosphatases in health and disease.. Biochim Biophys Acta Mol Cell Res 1866(1):124-143 PMID: 30401534
- 5. Verma D et al.. 2021. A dual-specificity phosphatase, MAP kinase phosphatase 1, positively regulates blue light-mediated seedling development in Arabidopsis.. Planta 253(6):131 PMID: 34057637
- 6. Zhan XL et al.. 1997. Differential regulation of FUS3 MAP kinase by tyrosine-specific phosphatases PTP2/PTP3 and dual-specificity phosphatase MSG5 in Saccharomyces cerevisiae.. Genes Dev 11(13):1690-702 PMID: 9224718
- 7. Chong ZZ et al.. 2003. The tyrosine phosphatase SHP2 modulates MAP kinase p38 and caspase 1 and 3 to foster neuronal survival.. Cell Mol Neurobiol 23(4-5):561-78 PMID: 14514016
- 8. Jiao H et al.. 2015. MAP kinase phosphatase 2 regulates macrophage-adipocyte interaction.. PLoS One 10(3):e0120755 PMID: 25816341
